Core Insights - The private equity securities industry is experiencing rapid growth in 2025, with product scale surpassing 7 trillion yuan and a significant increase in product registrations, nearly doubling from 2024, becoming the core engine of industry growth [1][2] - Nearly 90% of private equity securities products achieved positive returns, indicating a strong performance and increasing market recognition, leading to a more stable and sustainable growth trajectory for the industry [1][5] Product Registration and Strategy - A total of 12,645 private equity securities products were registered in 2025, a 99.54% increase from 6,337 in 2024, with stock strategies being the preferred choice, accounting for 65.86% of all registered products [2] - Quantitative products showed remarkable growth, with 5,617 registered, reflecting a 114.31% increase and making up 44.42% of total registrations, up from 41.68% in 2024 [2][3] Performance Metrics - Among the 9,934 private equity securities products with performance records, 8,915 achieved positive returns, resulting in a positive return rate of 89.74% and an average return rate of 25.68% [5] - Combination funds demonstrated strong performance, with 96.19% achieving positive returns and an average return rate of 18.30%, while multi-asset strategies also performed well with a 90.61% positive return rate [5] Industry Trends - The private equity securities industry is characterized by a solid core position of stock strategies, while multi-asset and derivative strategies are rapidly emerging, optimizing the strategic structure of the industry [4] - The rise of quantitative investment is becoming a strategic focus for leading institutions, with future competition expected to concentrate on specialization and refinement in niche areas [4][6]

Group 1 - The private equity securities investment products in 2025 have shown impressive performance, with 8,915 out of 9,934 products achieving positive returns, resulting in a positive return rate of 89.74% and an overall average return rate of 25.68% [1] - The stock strategy emerged as the top performer, with 5,680 out of 6,298 products yielding positive returns, a positive return rate of 90.19%, and an average return rate of 29.99%, indicating strong investment opportunities in the stock market for 2025 [1] - Among stock strategy sub-strategies, quantitative long strategies performed exceptionally well, with a positive return rate of 95.81% and an average return rate of 39.51% [1] Group 2 - The multi-asset strategy achieved a positive return rate of 90.61% with an average return rate of 22.06%, demonstrating strong risk management through flexible allocation across various asset classes [2] - Combination funds stood out as the most stable strategy in 2025, with a positive return rate of 96.19%, although the average return rate of 18.30% was lower than that of stock and multi-asset strategies [2] - Futures and derivatives strategies also performed well, with 84.86% of products achieving positive returns and an average return rate of 17.24% [2] Group 3 - The bond strategy maintained stable performance in 2025, with 670 out of 745 products achieving positive returns, resulting in a positive return rate of 89.93% and an average return rate of 9.56%, serving as a reliable asset allocation choice for low-risk investors [3] - The strong performance of private equity securities products in 2025 is attributed to three main factors: the resonance between macroeconomic environment and market trends, strong liquidity support from policy guidance, and the alignment of strategies with market structure [3] - The A-share market experienced an overall upward trend, with the ChiNext Index rising approximately 50%, providing a solid foundation for returns from stock strategy-focused private equity products [3]

Core Insights - In 2025, there was a significant surge in the registration of private securities products, with a total of 12,645 products registered, marking a year-on-year increase of 99.54% [1] - Stock strategies remain the preferred choice for private equity firms, with 8,328 stock strategy products registered, accounting for 65.86% of all registered products, indicating strong investor interest in stock assets [1] - Quantitative products showed remarkable performance, with 5,617 registered products, reflecting a year-on-year growth of 114.31%, and stock strategy quantitative products dominated this category [1][2] Group 1: Product Registration Trends - The registration of multi-asset strategies, futures, and derivatives strategies ranked second and third, with 1,806 and 1,274 products registered, representing 14.28% and 10.08% respectively [1] - Bond strategies and combination funds had 492 and 512 products registered, making up 3.89% and 4.05% of the total, contributing to a diversified landscape that caters to different risk preferences [1] Group 2: Quantitative Strategy Insights - Within the quantitative stock strategy segment, quantitative long strategies were particularly prominent, with 2,746 products registered, accounting for 48.89% of the total quantitative products [2] - Market-neutral strategies in the stock sector had 1,114 products registered, representing 19.83%, appealing to risk-averse investors due to their stable return characteristics [2] - Futures and derivatives quantitative strategies had 773 products registered, with quantitative CTA strategies being the core segment, comprising 12.93% of the total quantitative products [2] Group 3: Institutional Trends - The registration landscape showed a clear concentration among leading firms, with 26 out of 29 private equity firms that registered at least 50 products being billion-yuan firms [2] - Among these, Mingcang Investment led with 157 registered products, followed by Century Frontier, Black Wing Asset, and Kuande Private Equity with 147, 138, and 127 products respectively [2] - Quantitative investment has become the dominant strategy among leading private equity firms, with 24 out of 29 firms adopting this approach, highlighting its competitive advantages in discipline, risk control, and stable returns [3]

Core Viewpoint - The article emphasizes the commitment of the company to sustainable long-term value creation for investors, aligning with the recently released "Action Plan for Promoting High-Quality Development of Public Funds" which aims to reshape the industry ecosystem and prioritize investor interests [1] Group 1: Risk Management Framework - The company has established a comprehensive risk management system that balances daily management and crisis management, ensuring timely resolution of various investment risks [2] - A "three lines of defense" risk control system has been implemented, where investment personnel are responsible for the first line of defense, risk control and compliance personnel for the second, and audit personnel for the third, enhancing risk awareness and prevention [2] - The company has adopted a "3+3" management model focusing on market risk, credit risk, and liquidity risk, along with three risk assurance measures including new investment product evaluation and performance attribution [4] Group 2: Professional Capability - The company adheres to the philosophy that "risk management creates value," enhancing its professional risk management capabilities and improving the foresight of risk management processes [3] - The company has developed a robust investment risk management system that covers the entire investment risk lifecycle, from pre-investment to post-investment [3] Group 3: Technological Advancement - The company has been advancing towards a systematic, quantitative, and intelligent risk management approach since 2016, significantly improving risk management efficiency [5][6] - An intelligent risk control system has been developed, integrating applications, models, and data, and enhancing the company's risk management capabilities [6] Group 4: Collaborative Synergy - The company strengthens risk collaboration with its parent bank, China Construction Bank, leveraging shared resources and enhancing risk prediction capabilities [7] - Strategic cooperation with its second-largest shareholder, a major U.S. financial services firm, has been deepened to enhance professional capabilities in investment risk management [7] Group 5: Commitment to High-Quality Development - The company actively responds to the call for high-quality development in the industry, focusing on reforming its investment research system and optimizing product innovation [8][9] - Efforts are being made to enhance compliance culture and risk management capabilities, ensuring a robust risk management framework that protects investor assets [9][10]

Core Viewpoint - The article emphasizes the challenges of consistently outperforming in the private equity market, particularly in the context of the rapidly changing capital market environment since 2023, highlighting the importance of fund managers' research capabilities and strategy adaptation [2]. Summary by Strategy Quantitative Long-Only - A total of 16 quantitative long-only products have consistently ranked in the top tier from January to November 2023, 2024, and 2025, with notable contributions from firms like Minghong, Maoyuan, and Hanrong [2]. - As of November 2025, there are 640, 462, and 325 quantitative long-only products reported for the years 2023, 2024, and 2025 respectively, with only 16 products making it to the top 30% in all three years [3]. - The top five cumulative return products since 2023 are from firms including Huijing Asset, Shanghai Zijie Private Equity, and Abama Investment [3]. Subjective Long-Only - There are 14 subjective long-only products that have maintained top-tier rankings across the same periods, with notable firms like Kaishi Private Equity and Yidian Najin included [7]. - The number of subjective long-only products reported as of November 2025 is 1,089, 979, and 838 for the years 2023, 2024, and 2025 respectively, with only 14 products achieving top 30% rankings in all three years [7]. - The top five cumulative return products since 2023 are from Beiheng Fund, Ding Tai Sifang (Shenzhen), and Guangdong Guangjin [8]. CTA (Commodity Trading Advisor) - A total of 12 CTA products have consistently ranked in the top tier from January to November 2023, 2024, and 2025, with leading products from Guanjing Fund and other firms [13]. - The number of CTA products reported as of November 2025 is 256, 226, and 187 for the years 2023, 2024, and 2025 respectively, with only 12 products making it to the top 40% in all three years [13]. - The top five cumulative return products since 2023 are from Guanjing Fund, Gongqingcheng Guangju Xinghe Private Equity, and Caoben Investment [14]. Multi-Asset - There are 22 multi-asset products that have consistently ranked in the top tier from January to November 2023, 2024, and 2025, with significant contributions from firms like Luyuan and Junfu [18]. - The number of multi-asset products reported as of November 2025 is 414, 337, and 265 for the years 2023, 2024, and 2025 respectively, with only 22 products achieving top 40% rankings in all three years [18]. - The top five cumulative return products since 2023 are from Luyuan Private Equity, Henan Zhi Ying Private Equity, and Junfu Investment [18].

Market Overview - In 2023, major stock markets including A-shares, Hong Kong stocks, and US stocks experienced significant volatility due to tariff issues, but benefitted from liquidity easing and advancements in AI technology, leading to varying degrees of increases in major indices from January to November [2] - The ChiNext Index in A-shares led with an increase of over 42%, while the Hang Seng Index and Hang Seng Tech Index both rose over 25%. Among US stocks, the Nasdaq outperformed with a rise of approximately 21% [2] A-share Performance - The performance of major A-share indices from January to November 2023 is as follows: - Shanghai Composite Index: +16.02% - Shenzhen Component Index: +24.67% - ChiNext Index: +42.54% - CSI 300: +15.04% - CSI 500: +22.81% - CSI 1000: +23.10% - CSI 2000: +31.65% [3] Private Equity Performance - The overall performance of private equity products under billion-yuan private equity firms was impressive, with an average return of approximately 29.55% from January to November 2023 [3] - Among the 663 billion-yuan private equity products displayed on the platform, over 80% were equity strategy products, which yielded an average return of about 32.74%, significantly outperforming the Shanghai Composite Index and Shenzhen Component Index [4] Strategy Breakdown - Equity strategy products accounted for 535 products, with quantitative long products achieving an average return of over 44% [4] - Multi-asset strategy products totaled 64, yielding an average return of approximately 21.68% [4] - Bond strategy products numbered 36, while futures and derivatives strategy products accounted for 25, with average returns of 10.26% and 9.17% respectively [4] Top Performing Products - The top-performing quantitative long products included: - Longqi Technology's "Longqi Technology Innovation Selected No. 1 C Class" led with returns exceeding ***% [8] - Other notable products came from Stable Investment, Lingjun Investment, and others, with returns surpassing the set threshold [6][11] - In the subjective long category, the top product was "Yuanxin China Active Growth C Class" managed by Wang Aoye from Yuanxin Investment, with returns close to ***% [11] Multi-Asset Strategy Leaders - The leading products in the multi-asset strategy category included: - "Heiyi Preferred Growth No. 1 A Class" managed by Chen Zehao from Heiyi Asset, with returns exceeding ***% [18] - Other top products came from firms like Jiuzhi Investment and Yinye Investment [15]

Group 1 - The core viewpoint of the articles indicates that despite market fluctuations, both existing and new funds are optimistic about the medium to long-term performance of equity assets, as evidenced by a significant increase in private equity fund registrations and high stock positions [1][2][4]. - In November, over 1200 private equity securities investment funds were registered, marking a nearly 30% increase from October, with stock strategy funds accounting for 66.07% of new registrations [2][3]. - The stock private equity position index reached 82.97% as of November 21, reflecting a 1.84 percentage point increase from the previous week, indicating a strong commitment from existing funds [4][6]. Group 2 - The number of newly registered private equity funds in November was 1285, which is close to the year's highest monthly registration of 1302, showing a robust market activity [2][3]. - The majority of new registrations were in stock strategies, with 849 funds, while multi-asset and futures strategies also saw significant activity, with 193 and 121 new funds respectively [2][3]. - The average stock position for large private equity firms (over 10 billion) was reported at 89.23%, indicating a more aggressive stance among larger players [7]. Group 3 - The increase in private equity positions is attributed to two main factors: positive policy signals and the belief in the long-term value of A-shares, with recent market fluctuations providing good entry points [8]. - Investment focus is shifting towards technology and cyclical sectors, with firms expressing confidence in the recovery of corporate earnings, particularly in technology and advanced manufacturing sectors [9]. - Companies are expected to maintain high positions in sectors aligned with industrial trends, such as electronics, telecommunications, pharmaceuticals, and materials, as well as gold [9].

Group 1 - The private equity market in China is experiencing a surge in product registrations, with November seeing a 29.28% increase compared to the previous month, totaling 1,285 registered private equity securities products, marking the second-highest monthly registration this year [1] - Equity strategies remain the dominant focus for private equity firms, with 849 equity strategy products registered in November, accounting for 66.07% of total registrations, indicating strong investor interest despite recent adjustments in the A-share market [1] - Multi-asset strategies and futures and derivatives strategies are also maintaining high levels of activity, with 193 multi-asset strategy products registered, representing 15.02% of the total [1] Group 2 - Quantitative private equity products are particularly noteworthy, with 565 products registered in November, making up 43.97% of total registrations; equity strategies dominate this category as well, with 402 products registered [2] - A total of 719 private equity firms registered products in November, with 49 firms registering five or more products, highlighting a strong enthusiasm for product registration, especially among leading quantitative firms [2] - Century Frontier leads in product registrations with 20 products, followed by Starstone Investment with 15, and Mingchao Investment, Shanghai Xiaoyong Private Equity, and Tiansuan Quantitative each with 12 products [2] Group 3 - The A-share market has seen fluctuations around the 3,900-point mark, but long-term trends remain positive according to DWSQ, which believes that current adjustments do not alter the medium to long-term bullish outlook for A-shares [3] - Support for market risk appetite is expected from policy and liquidity environments, with expectations of the Federal Reserve entering a rate-cutting phase and overall liquidity in the A-share market remaining ample [3] - Corporate earnings are showing signs of stabilization, with the technology and advanced manufacturing sectors expected to contribute positively to market opportunities due to external demand and technological upgrades [3]

Core Insights - Multi-asset strategy products have gained popularity in recent years, with 1,400 products registered from January to October 2025, second only to stock strategy products [2] - The average annual return for multi-asset strategies is 20.37%, with a Sharpe ratio of 1.65, indicating stable performance compared to other strategies [3][4] Performance Overview - The average returns and performance metrics for various private equity strategies are as follows: - Stock Strategy: 29.54% return, 93.14% positive return ratio, Sharpe ratio of 1.56, volatility of 35.96%, and drawdown of 11.20% [3] - Multi-Asset Strategy: 20.37% return, 91.73% positive return ratio, Sharpe ratio of 1.65, volatility of 25.84%, and drawdown of 7.41% [3] - Composite Fund: 18.98% return, 96.34% positive return ratio, Sharpe ratio of 1.89, volatility of 15.61%, and drawdown of 6.62% [3] - Futures and Derivatives Strategy: 13.79% return, 82.49% positive return ratio, Sharpe ratio of 1.11, volatility of 48.73%, and drawdown of 8.06% [3] - Bond Strategy: 8.46% return, 92.10% positive return ratio, Sharpe ratio of 1.93, volatility of 11.76%, and drawdown of 3.21% [3] Reasons for Increased Attention - Single asset strategies face limitations in risk resistance, prompting managers to seek new alpha across asset classes [4] - In a low-interest-rate environment and under new asset management regulations, high-net-worth clients and managers need to balance net value fluctuations with absolute returns, which multi-asset strategies can provide [4] - The proliferation of tools such as risk parity, machine learning factors, and cross-asset real-time risk control platforms has enabled managers to effectively expand and reconstruct their research and investment systems [4] Sub-Strategy Performance - Among sub-strategies, macro strategies exhibit the highest average returns, positive return ratios, and Sharpe ratios [5][6] - Arbitrage strategies show lower volatility and drawdown compared to macro and composite strategies, indicating more stable performance [5]

Core Insights - The A-share market has seen a resurgence in 2023, leading to a significant increase in the issuance of private equity products, with a total of 994 private securities products registered in October, a 19.90% increase compared to the same month last year [1][3] - Stock strategy products remain the dominant category, accounting for 68.31% of the total registered products, indicating strong investor demand for equity assets [1][2] - Multi-asset strategy products have gained popularity, with 122 products registered in October, representing 12.27% of the total, reflecting a trend towards diversified investment strategies among private equity firms [1][2] Strategy Distribution - Quantitative stock strategy products have shown steady growth, with 333 out of 432 registered quantitative products being stock strategies, making up 77.08% of the total [2] - Futures and derivatives strategies have also emerged as a significant area for quantitative investment, with 50 products registered, accounting for 11.57% of the total quantitative products [2] - Bond strategies and combination funds have seen similar registration numbers, with 49 and 36 products respectively, representing 4.93% and 3.62% of the total [2] Market Dynamics - The increase in private securities product registrations is attributed to multiple factors, including the Shanghai Composite Index surpassing 4000 points, highlighting structural market opportunities [3] - Third-party sales institutions have intensified marketing efforts, further stimulating investor interest in private equity products [3] - The influx of northbound capital and a stable funding environment have provided favorable conditions for private equity operations, allowing firms to enhance product returns and innovate strategies [3]